# US 2018/0021483 A1 · Self-Cleaning Membrane for Medical Devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021483 A1
- Document ID: US20180021483A1
- Status: Published application
- Kind: A1
- Application number: 15/545,811
- Filed: 2016-01-27
- Published: 2018-01-25
- Earliest claimed: 2015-01-27
- Assignees: The Texas A&M University System
- Applicants: The Texas A&M University System
- Inventors: Melissa A. Grunlan; Gerard L. Cote; Alexander A. Abraham; Ruochong Fei; Andrea K. Locke
- Web page: https://patentgrep.com/patent/US20180021483A1

## CPC

- A61L 31/048: {obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/1473: invasive, e.g. introduced into the body by a catheter
- A61L 31/10: Macromolecular materials
- A61L 31/145: {Hydrogels or hydrocolloids}
- C08F 220/56: Acrylamide; Methacrylamide
- C08L 33/26: Homopolymers or copolymers of acrylamide or methacrylamide
- C08L 2203/02: for biomedical use
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The disclosure provides a method for cleaning an implanted medical device. In one embodiment, the method includes providing a medical device including a membrane; wherein the membrane comprises a thermoresponsive hydrogel including N-isopropylacrylamide (NIPAAm) or poly(N-isopropylacrylamide) (PNIPAAm), and a volume phase transition temperature (VPTT). The method also includes implanting the medical device into a target area; wherein the membrane temperature is maintained at substantially the same temperature as the target area; wherein temperature fluctuations within the target area that approach, meet and/or exceed the volume phase transition temperature induce deswelling or relative deswelling in the membrane and temperature fluctuations within the target area that are relatively lower and/or approach and/or fall below the volume phase transition temperature induce swelling or relative swelling in the membrane.

## Claims

### Claim 1

A method for cleaning an implanted medical device comprising:
providing a medical device comprising a membrane; wherein the membrane comprises a thermoresponsive hydrogel comprising N-isopropylacrylamide and a volume phase transition temperature;
implanting the medical device into a target area; wherein a membrane temperature is maintained at substantially the same temperature as the target area; wherein temperature fluctuations within the target area that approach, meet and/or exceed a volume phase transition temperature induce deswelling or relative deswelling in the membrane and temperature fluctuations within the target area that are relatively lower and/or approach and/or fall below the volume phase transition temperature induce swelling or relative swelling in the membrane.

### Claim 2 (depends on 1)

The method of claim 1, wherein the medical device comprises a glucose sensor.

### Claim 3 (depends on 1)

The method of claim 1, wherein the membrane further comprises N-vinylpyrollidone.

### Claim 4 (depends on 3)

The method of claim 3, wherein the N-vinylpyrollidone is present in an amount between about 1% to about 2% wt % by weight of the N-isopropylacrylamide.

### Claim 5 (depends on 1)

The method of claim 1, wherein the membrane is a single network membrane comprising a first network.

### Claim 6

A method for cleaning an implanted glucose biosensor comprising:
providing a glucose biosensor comprising a double network membrane comprising a first network and a second network; wherein the glucose biosensor measures a concentration of glucose; wherein the membrane comprises a thermoresponsive hydrogel comprising N-isopropylacrylamide, one or more polysiloxane colloidal nanoparticles, a comonomer of N-vinylpyrollidone, and a volume phase transition temperature;
implanting the glucose biosensor into a target area; wherein a membrane temperature is maintained at substantially the same temperature as the target area; wherein temperature fluctuations within the target area that exceed a volume phase transition temperature induce deswelling in the membrane and temperature fluctuations within the target area that fall behind the volume phase transition temperature induce swelling in the membrane.

### Claim 7 (depends on 6)

The method of claim 6, wherein the first network comprises N-vinylpyrollidone.

### Claim 8 (depends on 6)

The method of claim 6, wherein the membrane comprises poly(N-isopropylacrylamide).

### Claim 9 (depends on 1)

The method of claim 1, wherein the membrane does not require an external temperature regulation device to exceed or fall behind the volume phase transition temperature.

### Claim 10 (depends on 1)

The method of claim 1, wherein the membrane is cross linked.

### Claim 11 (depends on 1)

The method of claim 1, wherein the volume phase transition temperature is 38° C.

### Claim 12 (depends on 1)

The method of claim 1, wherein the membrane is cylindrical.

### Claim 13 (depends on 1)

The method of claim 1, wherein the deswelling of the membrane induces the removal of at least a portion of any attached cells from the membrane.

### Claim 14 (depends on 1)

The method of claim 1, wherein the membrane further comprises poly-electrolyte layers.

### Claim 15 (depends on 1)

The method of claim 1, wherein the membrane further comprises an electrostatic co-monomer.

### Claim 16 (depends on 15)

The method of claim 15, wherein the electrostatic co-monomer comprises 2-acrylamido-2-methylpropane sulfonic acid.

### Claim 17 (depends on 1)

The method of claim 1, wherein the membrane further comprises 2-acrylamido-2-methylpropane sulfonic acid or an electrostatically charged monomer.

### Claim 18 (depends on 6)

The method of claim 6, wherein the membrane further comprises 2-acrylamide-2-methylpropane sulfonic acid or an electrostatically charged monomer.
